Cited by 91Lipoproteins and Cardiovascular HealthLipid metabolism and disordersGenetic Associations and Epidemiology

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

Open access
Yamamura, T, Yamamoto, A, Sumiyoshi, T, Hiramori, K, Nishioeda, Y, Nambu, S·1984·Journal of Clinical Investigation

Abstract

We analyzed the heterogeneity of apo E in very low density lipoprotein from 58 hyperlipidemic subjects with or without atherosclerosis, 69 patients with ischemic heart disease, and 100 apparently healthy individuals. Apo E gene frequencies in the group of healthy individuals were comparable with those in German and American populations. The distribution of six common apo E phenotypes in the groups of hyperlipidemia and ischemic heart disease was similar to that in the healthy group. In addition to the three major isoforms of apolipoprotein E (apo E-4, E-3, and E-2) and the new one (apo E-5) which was recently found in this laboratory, we have discovered an additional series of components, which showed themselves as at least three bands on an isoelectric focusing gel in the region of E-VII through E-V, in four patients with hyperlipidemia and atherosclerosis. The new series of apo E components, named apo E-Suita, was identical with the ordinary apo E in its interaction with heparin-Sepharose gel and with anti-apo E antibody. The most basic component of apo E-Suita (E-VII) was the unsialylated form and other components (E-VI and E-V), the sialylated forms. Family studies revealed that apo E-Suita was determined by inheritance of a new apo E allele located at the same locus as the hitherto known apo E components. Apo E-5 and apo E-Suita isoproteins had isoelectric points more basic than apo E-3, the parent type, by two and four units of charge, respectively. While the apo E-Suita isoprotein had the same molecular weight as ordinary major apo E isoproteins, the molecular weight of the apo E-5 isoprotein was approximately 1,500-2,000 lower than the other apo E isoproteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The incidence of abnormal apo E components, including apo E-5 and apo E-Suita, was high among patients with hyperlipidemia and ischemic heart disease (7:127), while we could not find such components among 100 healthy individuals. Moreover, five of seven patients with the abnormal apo E had overt atherosclerotic disease. The findings suggest that these kinds of apolipoprotein mutation are closely related to the development of atherosclerosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci111532

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • rs121918392 (p.E21K) was defined as the APOE ε5 allele.

    “rs121918392 (p.E21K) was defined as the APOE ε5 allele29,32–34”

    From Association of rare <i>APOE</i> missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [29]

    The Introduction identifies apo E-5, and the discussion says it is controlled by an additional APOE allele. The paper does not identify that allele as rs121918392 or p.E21K; it says peptide-sequence analysis was still underway and tentatively suggests a deletion instead. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • rs140808909 (p.E262K) and rs190853081 (p.E263K) have been previously identified in Japanese patients with dyslipidemia and atherosclerosis and are defined as the APOE ε7 allele.

    “Both variants have been previously identified in Japanese patients with dyslipidemia and atherosclerosis and is defined as the APOE ε7 allele.29–31”

    From Association of rare <i>APOE</i> missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [29]

    The Introduction and Results describe apo E mutants found in patients with hyperlipidemia and atherosclerotic disease; the discussion suggests these mutants may be limited to the Japanese population. But the paper does not identify rs140808909 or rs190853081, establish the E262K or E263K substitutions, or define either as the APOE ε7 allele. It calls the new allele apo E-Suita; E-VII denotes a protein band, not an allele name. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • rs121918392 (p.E21K) was also associated with dyslipidemia and atherosclerosis.

    “rs121918392 (p.E21K) was also associated with dyslipidemia and atherosclerosis.29,32–34”

    From Association of rare <i>APOE</i> missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [29]

    The Results and Discussion (page unavailable) associate apo E-5 and apo E-Suita with hyperlipidemia and atherosclerotic disease. But the paper does not identify either mutant as rs121918392 (p.E21K); the Discussion says peptide sequence analysis was still underway. It therefore supports the disease association for the mutants studied, not its attribution to that specific variant. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The ε7 allele has been linked to dyslipidemia and atherosclerosis.

    “Notably, the ε7 allele has been linked to dyslipidemia and atherosclerosis,29–31 yet few studies have examined its binding to LDLR and heparin. 38”

    From Association of rare <i>APOE</i> missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [29]

    The Abstract and Results describe apo E-Suita in patients with hyperlipidemia and atherosclerosis, supporting the reported link. But the paper calls the inherited allele εSuita; E-VII is the name of an electrophoretic component, not an allele the paper identifies as ε7. It therefore does not establish the claim for an ε7 allele specifically. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yamamura, T., Yamamoto, A., Sumiyoshi, T., Hiramori, K., Nishioeda, Y., & Nambu, S.
Affiliations
National Cerebral and Cardiovascular Center (JP)
Venue
Journal of Clinical Investigation
Published
1984-10-01
Volume
74
Issue
4
Pages
1229-1237
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2058222155
Cited by
91
References
6
Citations by year
2026: 1 · 2025: 1 · 2022: 2 · 2021: 1 · 2019: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 2
FWCI
16.28
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (58480151)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
apolipoprotein E, atherosclerosis, hyperlipidemia, ischemic heart disease, VLDL, sialylation, apolipoprotein E isoforms, genetic susceptibility to atherosclerosis, type III hyperlipoproteinemia
MeSH terms
Antigen-Antibody Reactions, Apolipoproteins E, Arteriosclerosis, Cysteamine, Female, Gene Frequency, Humans, Hyperlipoproteinemia Type III, Lipoproteins, VLDL, Male, Mutation, Neuraminidase, Phenotype, Precipitin Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review